Gilead Sciences Inc. (GILD) Share Price ($):47.37 Price Change: -0.37 (-0.78%)

Expand Company Information
Volume 10,887,436 Avg Volume 9,805,173
Day's Low $46.52 Day's High $47.45
52-wk Low $22.66 52-wk High $49.48
Previous Close $47.74 Open Price $46.90
Dividend $NA Yield NA%
Market Cap 72,191,400,000 P/E (Forward) 23.69
Chart for GILD
Exchange: NASDAQ Industry: Pharmaceuticals & Biotechnology Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes: What's This?
    Find a Broker »
    Article Time Date Source
    Critical Alerts For Gilead, Total SA, Garmin, CIT, and Fortinet Released By InvestorsObserver 9:30 AM Apr 4, 2013  PR
    S&P 500 Climbs to New Record and EBay to Handle $110 Billion of Marketplace Volume in 2015 10:09 AM Apr 1, 2013  PR
    Quarterly Winners: Transports, Biotech, MLPs and … Spinoffs 9:49 AM Mar 29, 2013  Barrons.com
    Cyprus Secures Bailout but Major Exchanges still Decline. Shares of BlackBerry Take a Tumble after Downgrade 9:45 AM Mar 26, 2013  PR
    Gilead Announces Update on Phase 3 Study of Oral Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients 8:30 AM Mar 26, 2013  PR
    Gilead Has an Edge on Indenix in Suit 3:11 PM Mar 25, 2013  Barrons.com
    Morning Research on Gilead Sciences, Halozyme Therapeutics, InterMune, and Seattle Genetics 8:01 AM Mar 25, 2013  PR
    A Rewarding Development 2:18 PM Mar 25, 2013  Barrons.com
    Idenix Loses 1st-Stage of Drug Compounds Patent Case 5:25 PM Mar 22, 2013 Dow Jones Global News Select
    Gentium Gets Negative Opinion From CHMP; Biogen, Others Get Positive Opinions 9:18 AM Mar 22, 2013 Dow Jones Global News Select
    European CHMP Adopts Positive Opinion for Stribild(R) , a Once-Daily, Integrase Inhibitor-Based, Single Tablet Regimen for the Treatment of HIV-1 Infection 8:30 AM Mar 22, 2013  PR
    Upcoming Results from Clinical Trials - Research Report on Gilead Sciences, Celgene Corporation, Sinovac Biotech, NPS Pharmaceuticals and ZIOPHARM Oncology 8:00 AM Mar 18, 2013  PR
    A Forward Look, The Year Ahead - Research Report on Kellogg Company, General Mills, Inc., Gilead Sciences, Inc., Celgene Corporation and The Coca-Cola Company 8:01 AM Mar 13, 2013  PR
    Gilead's Ranexa(R) Reduces Angina Frequency in -2- 2:57 PM Mar 10, 2013  PR
    Gilead's Ranexa(R) Reduces Angina Frequency in Study of Chronic Angina Patients With Type 2 Diabetes 2:57 PM Mar 10, 2013  PR
    Pfizer Stops Developing Hepatitis C Drug 1:02 PM Mar 8, 2013  WSJ.com
    Pfizer Stops Developing Hepatitis C Drug, Cites Strategic Review 12:11 PM Mar 8, 2013 Dow Jones Global News Select
    All in the Family 3:54 PM Feb 12, 2013  Barrons.com
    The Morning Ledger: Pharma CFOs Whittle Down Tax Rates 7:10 AM Feb 7, 2013  WSJ.com
    Drug Firms Lower Their Tax Rates With New Strategies 7:16 PM Feb 6, 2013  WSJ.com
    • Print Snapshot
    • Stock Compare
    • Receive Stock Alerts
    • Receive News Alerts
    • Glossary
    • RSS
    • Price Check Calculator
    • Annual Reports
    tools

    Stock Screener

    Portfolio Tracker

    See More Tools